Serra-Plex
Serra-Plex, licence 80057492: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Vitazan Herbs and Vitamins Inc
- NPN or DIN-HM
- 80057492
- Status
- Inactive licence
- Licence date
- 20 January 2015
- Revision date
- Not provided
- Form
- Capsule, libération-retardée
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- À vérifier
Serratiopeptidase is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
POL-NF-00692. Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Camellia sinensis Source : Feuille Potency : 0.0 8-10 % Caffeine | Not specified | Not calculated |
| Camellia sinensis Source : Feuille Potency : 75.0 % EGCG | 21.0 mg | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 3600000.0 FCC PU | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 100.0 mg | Not calculated |
| Serratiopeptidase Source : Serratia marcescens | 25.0 mg | Not calculated |
| Serratiopeptidase Source : Cellule entière | 25.0 mg | Not calculated |
| Boswellia serrata Source : Boswellia serrata- Résine de gomme Potency : 70.0 % Organic acids | 100.0 mg | Not calculated |
| Piper nigrum Source : Fruit Potency : 95.0 % piperine | 3.0 mg | Not calculated |
| (1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione Source : Curcuma longa - rhizome Potency : 95.0 % curcuminoids | 80.0 mg | Not calculated |
| Harpagophytum procumbens Source : Racine(s) secondaire(s) tubérisée(s) | 120.0 mg | Not calculated |
| Vitis Vinifera Source : Graine(s) | 30.0 mg | Not calculated |
| (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol Source : Marigold flower- Oleoresin | 1.0 mg | Not calculated |
| Lycopène tout trans Source : Chair (fruit) | 2.5 mg | Not calculated |
| Serratiopeptidase Source : Serratia marcescens | 60000.0 SU | Not calculated |
| Serratiopeptidase Source : Cellule entière | 60000.0 SU | Not calculated |
| Boswellia serrata Source : Boswellia serrata- Résine de gomme Potency : 35.0 % Boswellia acid | Not specified | Not calculated |
Non-medicinal ingredients
Eau purifiée, Cellulose microcristalline, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce (symptoms such as) pain, quantity of secretion, inability to perceive smell and stuffy nose from ear, nose and throat infections. Mucolytic enzyme. Helps reduce (relieve) postoperative cheek swelling and/or pain after dental surgery. Used in herbal medicine to help relieve minor pain, swelling and inflammation (anti-inflammatory).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80057492
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.